시장보고서
상품코드
1429343

세계 바이오로직스 시장 보고서(2024년)

Biologics Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 400 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

바이오로직스 시장 규모는 향후 수년간 빠르게 성장할 것으로 예상됩니다. 2028년 복합 연간 성장률(CAGR) 10.0%를 나타낼 전망이며 6,663억 1,000만 달러로 성장할 것으로 예상됩니다. 예상되는 성장은 기금 증가, 기술 진보, 건강 관리 접근 개선, 경구 생체 논리의 강력한 R&D 활동, 주사보다 정제 선호도, 생체 논리의 파이프라인 성장으로 촉진됩니다. 주요 동향으로는 바이오로직스의 개발 강화를 위한 개정규제의 활용, 이러한 의약품 수요를 활용하는 방향으로의 이행, 혁신적인 바이오로직스 연구개발에 대한 투자 증가, 복잡한 질환을 치료하기 위해의 생물학에 초점을 맞춘 조사를 들 수 있습니다.

개인화된 의료에 대한 수요 증가는 확실히 생물학적 시장의 성장을 지원하는 중요한 원동력이 되고 있습니다. 맞춤형 의료는 정밀의료로도 알려져 있으며 개별 환자의 특성에 맞게 치료와 건강 관리를 조정합니다. 이 접근법은 환자 특유의 유전적 및 임상적 프로파일에 기초하여 생물학적 치료를 맞춤화할 수 있게 하여 건강 관리 산업에 큰 변화를 가져옵니다. Personalized Medicine Coalition 보고서에서 입증된 바와 같이, 2021년 신약 승인의 상당 부분, 약 35%가 맞춤형 의료이며, 보다 광범위한 제약 상황에서 이 분야의 중요성이 증가하고 있음 . 그러므로 이 개인화된 의료에 대한 수요의 급증은 생물학적 시장의 성장을 가속할 것으로 예상됩니다.

이 시기, 기술은 시장 확대의 지속적인 원동력으로 두드러지고 있습니다. 특히 생리학 시뮬레이션 모델링은 중요한 발전을 위해 준비되어 있으며 시장 성장에 기여할 것으로 예상됩니다. 이 분야의 진보는 효율성 향상을 약속하고 있으며, 생물학적 시장 내의 기업들은 이러한 진보로부터 혜택을 누릴 수 있습니다. 주목할만한 예로는 엘리 릴리 및 화이자와 같은 제약 선도적 인 Amazon의 Elastic Compute Cloud(EC2) 플랫폼 채택이 포함됩니다. 이 회사들은 초기 의약품에서 시뮬레이션 모델을 실행하는 데이 기술을 활용하여 시뮬레이션에 필요한 시간을 크게 단축했습니다. 예를 들어, 이전에는 몇 주가 걸린 작업이 몇 시간 내에 완료될 수 있습니다. Lilly의 개방형 혁신 의약품 프로그램과 같은 이니셔티브는 생물학적 연구 개발을 강화하기 위한 노력을 더욱 강조합니다. 이러한 기술의 진보는 공정을 간소화하고 비용을 절감하고 생체 로직의 개발 단계를 가속화할 것으로 기대되고 있으며, 기업은 제품을 보다 빠르게 시장에 출시할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 제품/서비스 분석 - 제품/서비스 예

  • 바이오로직스공급망 분석
    • 바이오로직스 리소스
    • 바이오로직스 제조업체
    • 바이오로직스의 판매자 및 소매업체
    • 바이오로직스의 최종 사용자
  • 바이오로직스의 고객 정보

제4장 시장 동향과 전략

제5장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나,러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제6장 세계 시장 규모와 성장

  • 세계 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계 시장 규모 실적과 성장(2018년-2023년)
  • 세계 시장 규모 예측과 성장(2023년-2028년, 2033년)

제7장 시장 세분화

  • 세계 바이오로직스 시장 : 유형별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 단클론항체(MAbS)
  • 치료용 단백질
  • 백신
  • 세계 바이오로직스 시장 : 의약품 분류별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 브랜드 의약품
  • 제네릭 의약품
  • 세계 바이오로직스 시장 : 투여 경로별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 경구
  • 비경구
  • 기타
  • 세계 바이오로직스 시장 : 구매 모드별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 처방전 기반의 의약품
  • 시판약
  • 세계 바이오로직스 시장 : 유통 채널별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 병원 약국
  • 소매 약국/ 약국
  • 기타

제8장 지역 및 국가 분석

  • 세계 바이오로직스 시장 : 지역별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 세계 바이오로직스 시장 : 국가별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)

제9장 아시아태평양 시장

제10장 중국 시장

제11장 인도 시장

제12장 일본 시장

제13장 호주 시장

제14장 인도네시아 시장

제15장 한국 시장

제16장 방글라데시 시장

제17장 태국 시장

제18장 베트남 시장

제19장 말레이시아 시장

제20장 싱가포르 시장

제21장 필리핀 시장

제22장 홍콩 시장

제23장 뉴질랜드 시장

제24장 서유럽 시장

제25장 영국 시장

제26장 독일 시장

제27장 프랑스 시장

제28장 이탈리아 시장

제29장 스페인 시장

제30장 오스트리아 시장

제31장 벨기에 시장

제32장 덴마크 시장

제33장 핀란드 시장

제34장 아일랜드 시장

제35장 네덜란드 시장

제36장 노르웨이 시장

제37장 포르투갈 시장

제38장 스웨덴 시장

제39장 스위스 시장

제40장 동유럽 시장

제41장 러시아 시장

제42장 체코공화국 시장

제43장 폴란드 시장

제44장 루마니아 시장

제45장 우크라이나 시장

제46장 북미 시장

제47장 미국 시장

제48장 캐나다 시장

제49장 멕시코 시장

제50장 남미 시장

제51장 브라질 시장

제52장 칠레 시장

제53장 아르헨티나 시장

제54장 콜롬비아 시장

제55장 페루 시장

제56장 중동시장

제57장 사우디아라비아 시장

제58장 이스라엘 시장

제59장 이란 시장

제60장 터키 시장

제61장 아랍에미리트(UAE) 시장

제62장 아프리카 시장

제63장 이집트 시장

제64장 나이지리아 시장

제65장 남아프리카 시장

제66장 경쟁 구도와 기업 프로파일

  • 바이오로직스 시장 경쟁 구도
  • 바이오로직스 시장 기업 프로파일
    • Merck &Co., Inc.
    • AbbVie Inc.
    • F. Hoffmann-La Roche AG
    • Johnson &Johnson
    • Pfizer Inc.

제67장 기타 선도적이고 혁신적인 기업

  • Bristol Myers Squibb Company
  • Sanofi SA
  • GlaxoSmithKline Plc.
  • Eli Lilly and Company
  • Amgen Inc.
  • Wockhardt
  • Zydus Cadilla
  • Asahi Glass Co. Ltd.
  • China Biologic Products Holdings Inc.
  • China Regenerative Medicine International
  • ABLbio
  • Adimmune
  • Henlius
  • Innovent Biologics
  • Bio-Thera

제68장 경쟁 벤치마킹

제69장 경쟁 대시보드

제70장 주요 인수합병(M&A)

제71장 미래 전망과 가능성 분석

제72장 부록

BJH 24.03.21

Biologics are medications derived from organic materials and are utilized to treat a diverse range of illnesses, particularly immune-related conditions such as Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. One intriguing aspect is that biologics are sourced from various natural materials, including carbohydrates, proteins, nucleic acids, or complex mixtures of these substances.

The primary types of biologics include monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are engineered in laboratories to target specific infections. These biologics can be administered through various routes, including oral, parenteral, and others, and are distributed through channels such as hospital pharmacies, retail pharmacies/drug stores, and others.

The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biologics market size has grown strongly in recent years. It will grow from $416.65 billion in 2023 to $454.4 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth observed during the historic period can be attributed to several factors, including an aging population, government initiatives, the ability to command high prices, and an increased need for immunology.

The biologics market size is expected to see rapid growth in the next few years. It will grow to $666.31 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The forecasted growth is driven by increased funding, technological advancements, improved healthcare access, robust research and development activities for oral biologics, a preference for pills over injections, and a growing pipeline of biologics. Key trends include leveraging revised regulations for enhanced biologics development, a shift towards capitalizing on the demand for these drugs, increased investment in innovative biologics R&D, and research focused on biologics for treating complex diseases.

The increasing demand for personalized medicine is indeed a key driver behind the growth of the biologics market. Personalized medicine, also known as precision medicine, tailors medical treatment and healthcare to individual patient characteristics. This approach allows for the customization of biologic treatments based on a patient's specific genetic and clinical profile, marking a transformative shift in the healthcare industry. As evidenced by the Personalized Medicine Coalition's report, a substantial portion, approximately 35%, of new drug approvals in 2021 were personalized medicines, showcasing the rising significance of this sector within the broader pharmaceutical landscape. Consequently, this surge in demand for personalized medicine is expected to drive the growth of the biologics market.

Technology stands out as a continued driving force behind market expansion in this period. Physiology simulation modeling, in particular, is poised for significant development and is anticipated to contribute to market growth. Advances in this field promise greater efficiencies, and companies within the biologics market are likely to benefit from such advancements. Notable instances include the adoption of Amazon's Elastic Compute Cloud (EC2) platform by pharmaceutical giants such as Eli Lilly and Pfizer. These companies utilize this technology for conducting simulation models in early drug discovery, significantly reducing the time required for simulations. For instance, tasks that traditionally took weeks can now be completed within hours. Initiatives such as Lilly's Open Innovation Drug Discovery program further underscore efforts to enhance biologics research and development. These technological advancements are expected to streamline processes, lower costs, and accelerate the development phase of biologics, enabling companies to introduce their products to market more swiftly.

The focus of major companies in the biologics industry on developing innovative products, such as oncology biosimilars, reflects their strategic initiatives to strengthen market positions and gain competitive advantages. Oncology biosimilars, specifically designed to treat cancer, are akin to existing biologic drugs and offer highly similar alternatives in terms of efficacy and safety. An example of this pursuit is seen in the collaboration between Biocon Biologics Limited and Viatris Inc., which led to the launch of Abevmy in Canada in May 2022. Abevmy is an oncology biosimilar utilized for cancer treatment, exhibiting similarity to an already authorized biological medicine.

The revisions made by the US Food and Drug Administration (FDA) in its regulations concerning biologics signify a shift toward eliminating outdated requirements. The alterations allow drug manufacturers to adopt new manufacturing technologies and testing capabilities. Specifically, the FDA has amended regulations to enable the sourcing of standard preparations, critical in ensuring the safety, purity, and potency of biologics, from sources beyond the FDA's Center for Biologics Evaluation and Research (CBER). Additionally, the FDA has removed the minimal potency limits rule (Section 610.21 of FDA code) pertaining to certain antibodies and antigens. Furthermore, updates in regulations (Section 610.53 of FDA code) concerning storage periods and conditions for biologics have been introduced. These regulatory amendments aim to enhance flexibility and promote the adoption of contemporary scientific technologies in the manufacturing processes of licensed biological products, fostering innovation and progress in the biologics industry.

Major companies operating in the biologics market report are Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Wockhardt, Zydus Cadilla, Asahi Glass Co. Ltd., China Biologic Products Holdings Inc., China Regenerative Medicine International, ABLbio, Adimmune, Henlius, Innovent Biologics, Bio-Thera, Hisun Pharma, 3SBio, Beijing ShuangLu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Biocon, Dr.Reddy's, Mylan, Kyowa Hakko Kirin, Takeda, Mitsubishi Tanabe, AGC Biologics, Tonghua Dongbao Pharmaceutical Co., China Regenerative Medicine International, Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Biogen Inc., Novartis, Apotex, Gilead Sciences, Bayer, Abbott Laboratories

North America was the largest region in the biologics market in 2023. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The biologics market consists of sales of tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
  • 2) By Drug Classification: Branded Drugs; Generic Drugs
  • 3) By Route Of Administration: Oral; Other Route Of Administration
  • 4) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
  • Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines
  • Companies Mentioned: Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Market Characteristics

3. Biologics Product/Service Analysis -Product/Service Examples

  • 3.1. Biologics Supply Chain Analysis
    • 3.1.1. Biologics Resources
    • 3.1.2. Biologics Manufacturers
    • 3.1.3. Biologics Distributors and Retailers
    • 3.1.4. Biologics End Users
  • 3.2. Biologics Customer Information

4. Biologics Market Trends And Strategies

5. Biologics Market - Macro Economic Scenario

  • 5.1. Impact Of High Inflation On The Market
  • 5.2. Ukraine-Russia War Impact On The Market
  • 5.3. COVID-19 Impact On The Market

6. Global Biologics Market Size and Growth

  • 6.1. Global Biologics Market Drivers and Restraints
    • 6.1.1. Drivers Of The Market
    • 6.1.2. Restraints Of The Market
  • 6.2. Global Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 6.3. Global Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

7. Biologics Market Segmentation

  • 7.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Monoclonal Antibodies (MAbS)
  • Therapeutic Proteins
  • Vaccines
  • 7.2. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 7.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administration
  • 7.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
  • 7.5. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Other Distribution Channels

8. Biologics Market Regional And Country Analysis

  • 8.1. Global Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.2. Global Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. Asia-Pacific Biologics Market

  • 9.1. Asia-Pacific Biologics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 9.2. Asia-Pacific Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 9.3. Asia-Pacific Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 9.4. Asia-Pacific Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10. China Biologics Market

  • 10.1. China Biologics Market Overview
  • 10.2. China Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 10.3. China Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 10.4. China Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

11. India Biologics Market

  • 11.1. India Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. India Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. India Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Japan Biologics Market

  • 12.1. Japan Biologics Market Overview
  • 12.2. Japan Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Japan Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.4. Japan Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Australia Biologics Market

  • 13.1. Australia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Australia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Australia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. Indonesia Biologics Market

  • 14.1. Indonesia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. Indonesia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. Indonesia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. South Korea Biologics Market

  • 15.1. South Korea Biologics Market Overview
  • 15.2. South Korea Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. South Korea Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. South Korea Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. Bangladesh Biologics Market

  • 16.1. Bangladesh, Biologics Historic Market, 2018 - 2023, $ Billion
  • 16.2. Bangladesh, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

17. Thailand Biologics Market

  • 17.1. Thailand, Biologics Historic Market, 2018 - 2023, $ Billion
  • 17.2. Thailand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

18. Vietnam Biologics Market

  • 18.1. Vietnam, Biologics Historic Market, 2018 - 2023, $ Billion
  • 18.2. Vietnam, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

19. Malaysia Biologics Market

  • 19.1. Malaysia, Biologics Historic Market, 2018 - 2023, $ Billion
  • 19.2. Malaysia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

20. Singapore Biologics Market

  • 20.1. Singapore, Biologics Historic Market, 2018 - 2023, $ Billion
  • 20.2. Singapore, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

21. Philippines Biologics Market

  • 21.1. Philippines, Biologics Historic Market, 2018 - 2023, $ Billion
  • 21.2. Philippines, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

22. Hong kong Biologics Market

  • 22.1. Hong Kong, Biologics Historic Market, 2018 - 2023, $ Billion
  • 22.2. Hong Kong, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

23. New Zealand Biologics Market

  • 23.1. New Zealand, Biologics Historic Market, 2018 - 2023, $ Billion
  • 23.2. New Zealand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

24. Western Europe Biologics Market

  • 24.1. Western Europe Biologics Market Overview
  • 24.2. Western Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. Western Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. Western Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. UK Biologics Market

  • 25.1. UK Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.2. UK Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. UK Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. Germany Biologics Market

  • 26.1. Germany Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.2. Germany Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. Germany Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. France Biologics Market

  • 27.1. France Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. France Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. France Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Italy Biologics Market

  • 28.1. Italy Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.2. Italy Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Italy Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Spain Biologics Market

  • 29.1. Spain Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.2. Spain Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Spain Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Austria Biologics Market

  • 30.1. Austria, Biologics Historic Market, 2018 - 2023, $ Billion
  • 30.2. Austria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

31. Belgium Biologics Market

  • 31.1. Belgium, Biologics Historic Market, 2018 - 2023, $ Billion
  • 31.2. Belgium, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

32. Denmark Biologics Market

  • 32.1. Denmark, Biologics Historic Market, 2018 - 2023, $ Billion
  • 32.2. Denmark, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

33. Finland Biologics Market

  • 33.1. Finland, Biologics Historic Market, 2018 - 2023, $ Billion
  • 33.2. Finland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

34. Ireland Biologics Market

  • 34.1. Ireland, Biologics Historic Market, 2018 - 2023, $ Billion
  • 34.2. Ireland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

35. Netherlands Biologics Market

  • 35.1. Netherlands, Biologics Historic Market, 2018 - 2023, $ Billion
  • 35.2. Netherlands, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

36. Norway Biologics Market

  • 36.1. Norway, Biologics Historic Market, 2018 - 2023, $ Billion
  • 36.2. Norway, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

37. Portugal Biologics Market

  • 37.1. Portugal, Biologics Historic Market, 2018 - 2023, $ Billion
  • 37.2. Portugal, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

38. Sweden Biologics Market

  • 38.1. Sweden, Biologics Historic Market, 2018 - 2023, $ Billion
  • 38.2. Sweden, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

39. Switzerland Biologics Market

  • 39.1. Switzerland, Biologics Historic Market, 2018 - 2023, $ Billion
  • 39.2. Switzerland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

40. Eastern Europe Biologics Market

  • 40.1. Eastern Europe Biologics Market Overview
  • 40.2. Eastern Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 40.3. Eastern Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 40.4. Eastern Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

41. Russia Biologics Market

  • 41.1. Russia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 41.2. Russia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 41.3. Russia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

42. Czech Republic Biologics Market

  • 42.1. Czech Republic, Biologics Historic Market, 2018 - 2023, $ Billion
  • 42.2. Czech Republic, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

43. Poland Biologics Market

  • 43.1. Poland, Biologics Historic Market, 2018 - 2023, $ Billion
  • 43.2. Poland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

44. Romania Biologics Market

  • 44.1. Romania, Biologics Historic Market, 2018 - 2023, $ Billion
  • 44.2. Romania, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

45. Ukraine Biologics Market

  • 45.1. Ukraine, Biologics Historic Market, 2018 - 2023, $ Billion
  • 45.2. Ukraine, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

46. North America Biologics Market

  • 46.1. North America Biologics Market Overview
  • 46.2. North America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 46.3. North America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 46.4. North America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

47. USA Biologics Market

  • 47.1. USA Biologics Market Overview
  • 47.2. USA Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 47.3. USA Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 47.4. USA Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

48. Canada Biologics Market

  • 48.1. Canada Biologics Market Overview
  • 48.2. Canada Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 48.3. Canada Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 48.4. Canada Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

49. Mexico Biologics Market

  • 49.1. Mexico, Biologics Historic Market, 2018 - 2023, $ Billion
  • 49.2. Mexico, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

50. South America Biologics Market

  • 50.1. South America Biologics Market Overview
  • 50.2. South America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 50.3. South America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 50.4. South America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

51. Brazil Biologics Market

  • 51.1. Brazil Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 51.2. Brazil Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 51.3. Brazil Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

52. Chile Biologics Market

  • 52.1. Chile, Biologics Historic Market, 2018 - 2023, $ Billion
  • 52.2. Chile, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

53. Argentina Biologics Market

  • 53.1. Argentina, Biologics Historic Market, 2018 - 2023, $ Billion
  • 53.2. Argentina, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

54. Colombia Biologics Market

  • 54.1. Colombia, Biologics Historic Market, 2018 - 2023, $ Billion
  • 54.2. Colombia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

55. Peru Biologics Market

  • 55.1. Peru, Biologics Historic Market, 2018 - 2023, $ Billion
  • 55.2. Peru, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

56. Middle East Biologics Market

  • 56.1. Middle East Biologics Market Overview
  • 56.2. Middle East Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 56.3. Middle East Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 56.4. Middle East Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

57. Saudi Arabia Biologics Market

  • 57.1. Saudi Arabia, Biologics Historic Market, 2018 - 2023, $ Billion
  • 57.2. Saudi Arabia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

58. Israel Biologics Market

  • 58.1. Israel, Biologics Historic Market, 2018 - 2023, $ Billion
  • 58.2. Israel, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

59. Iran Biologics Market

  • 59.1. Iran, Biologics Historic Market, 2018 - 2023, $ Billion
  • 59.2. Iran, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

60. Turkey Biologics Market

  • 60.1. Turkey, Biologics Historic Market, 2018 - 2023, $ Billion
  • 60.2. Turkey, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

61. United Arab Emirates Biologics Market

  • 61.1. United Arab Emirates, Biologics Historic Market, 2018 - 2023, $ Billion
  • 61.2. United Arab Emirates, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

62. Africa Biologics Market

  • 62.1. Africa Biologics Market Overview
  • 62.2. Africa Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 62.3. Africa Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 62.4. Africa Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

63. Egypt Biologics Market

  • 63.1. Egypt, Biologics Historic Market, 2018 - 2023, $ Billion
  • 63.2. Egypt, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

64. Nigeria Biologics Market

  • 64.1. Nigeria, Biologics Historic Market, 2018 - 2023, $ Billion
  • 64.2. Nigeria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

65. South Africa Biologics Market

  • 65.1. South Africa, Biologics Historic Market, 2018 - 2023, $ Billion
  • 65.2. South Africa, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

66. Biologics Market Competitive Landscape And Company Profiles

  • 66.1. Biologics Market Competitive Landscape
  • 66.2. Biologics Market Company Profiles
    • 66.2.1. Merck & Co., Inc.
      • 66.2.1.1. Overview
      • 66.2.1.2. Products and Services
      • 66.2.1.3. Strategy
      • 66.2.1.4. Financial Performance
    • 66.2.2. AbbVie Inc.
      • 66.2.2.1. Overview
      • 66.2.2.2. Products and Services
      • 66.2.2.3. Strategy
      • 66.2.2.4. Financial Performance
    • 66.2.3. F. Hoffmann-La Roche AG
      • 66.2.3.1. Overview
      • 66.2.3.2. Products and Services
      • 66.2.3.3. Strategy
      • 66.2.3.4. Financial Performance
    • 66.2.4. Johnson & Johnson
      • 66.2.4.1. Overview
      • 66.2.4.2. Products and Services
      • 66.2.4.3. Strategy
      • 66.2.4.4. Financial Performance
    • 66.2.5. Pfizer Inc.
      • 66.2.5.1. Overview
      • 66.2.5.2. Products and Services
      • 66.2.5.3. Strategy
      • 66.2.5.4. Financial Performance

67. Biologics Market Other Major And Innovative Companies

  • 67.1. Bristol Myers Squibb Company
  • 67.2. Sanofi S.A.
  • 67.3. GlaxoSmithKline Plc.
  • 67.4. Eli Lilly and Company
  • 67.5. Amgen Inc.
  • 67.6. Wockhardt
  • 67.7. Zydus Cadilla
  • 67.8. Asahi Glass Co. Ltd.
  • 67.9. China Biologic Products Holdings Inc.
  • 67.10. China Regenerative Medicine International
  • 67.11. ABLbio
  • 67.12. Adimmune
  • 67.13. Henlius
  • 67.14. Innovent Biologics
  • 67.15. Bio-Thera

68. Global Biologics Market Competitive Benchmarking

69. Global Biologics Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Biologics Market

71. Biologics Market Future Outlook and Potential Analysis

  • 71.1 Biologics Market In 2028 - Countries Offering Most New Opportunities
  • 71.2 Biologics Market In 2028 - Segments Offering Most New Opportunities
  • 71.3 Biologics Market In 2028 - Growth Strategies
    • 71.3.1 Market Trend Based Strategies
    • 71.3.2 Competitor Strategies

72. Appendix

  • 72.1. Abbreviations
  • 72.2. Currencies
  • 72.3. Historic And Forecast Inflation Rates
  • 72.4. Research Inquiries
  • 72.5. The Business Research Company
  • 72.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제